Characterization of the LPS-stimulated expression of EP2 and EP4 prostaglandin E receptors in mouse macrophage-like cell line, J774.1.

The expression of prostaglandin (PG) E receptor subtypes were characterized in J774.1, a mouse macrophage-like cell line. EP2- and EP4-mRNAs were found to be expressed. The expression of EP2 mRNA increased by the addition of lipopolysaccharide (LPS) in a dose-dependent manner. EP2 mRNA rapidly increased by more than 5-fold of the control level at 1 h, and decreased after 4 h. EP4 mRNA increased by only 2-fold of the control at 2 h. Gamma interferon inhibited both basal and LPS-induced expression of EP2 mRNA but did not affect the expression level of EP4 mRNA. When tumor necrosis factor-alpha (TNF-alpha) accumulation was measured after the treatment ofthe cells with LPS for 90 min, PGE2 was found to inhibit this accumulation, but butaprost, an EP2-selective agonist, did not. When TNF-alpha release was measured after the treatment of the cells with LPS for 8 h, accumulation was inhibited by butaprost as well as PGE2. These results indicated that the inhibitory effects of PGE2 on TNF-alpha production are mediated by EP2 and EP4 in macrophages, and that expression regulation of EP2 and EP4 in macrophages is quite different.

[1]  Y. Sugimoto,et al.  Characterization of the gene for the mouse prostaglandin E receptor subtype EP2: tissue-specific initiation of transcription in the macrophage and the uterus. , 1998, The Biochemical journal.

[2]  P. Barnes,et al.  Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide‐induced tumour necrosis factor‐α generation , 1997, British journal of pharmacology.

[3]  M. Murakami,et al.  Concordant induction of prostaglandin E2 synthase with cyclooxygenase-2 leads to preferred production of prostaglandin E2 over thromboxane and prostaglandin D2 in lipopolysaccharide-stimulated rat peritoneal macrophages. , 1997, Biochemical and biophysical research communications.

[4]  B. Wingerd,et al.  Prostanoid Receptors of Murine NIH 3T3 and RAW 264.7 Cells , 1996, The Journal of Biological Chemistry.

[5]  A. Ichikawa,et al.  Two Gs-coupled prostaglandin E receptor subtypes, EP2 and EP4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist. , 1996, Molecular pharmacology.

[6]  L. Owen-Schaub,et al.  Human Tumor Necrosis Factor Receptor p75/80 (CD120b) Gene Structure and Promoter Characterization* , 1996, The Journal of Biological Chemistry.

[7]  S. Narumiya,et al.  The mouse prostaglandin E receptor EP2 subtype: cloning, expression, and Northern blot analysis , 1995, FEBS letters.

[8]  S. Narumiya,et al.  Identification of prostaglandin E receptor ‘EP2’ cloned from mastocytoma cells as EP4 subtype , 1995, FEBS letters.

[9]  K. Chadee,et al.  Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages. , 1995, Biochemical and biophysical research communications.

[10]  S. Chavali,et al.  Effects of prostaglandin E2, cholera toxin and 8-bromo-cyclic AMP on lipopolysaccharide-induced gene expression of cytokines in human macrophages. , 1995, Immunology.

[11]  S. Narumiya,et al.  VIII. International union of pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes , 1994 .

[12]  R. A. Coleman,et al.  A novel inhibitory prostanoid receptor in piglet saphenous vein. , 1994, Prostaglandins.

[13]  S. Ito,et al.  Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor. , 1993, The Journal of biological chemistry.

[14]  Y. Sugimoto,et al.  Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype. , 1993, The Journal of biological chemistry.

[15]  F. Amano,et al.  A lipopolysaccharide (LPS)-resistant mutant isolated from a macrophagelike cell line, J774.1, exhibits an altered activated-macrophage phenotype in response to LPS , 1991, Infection and immunity.

[16]  P. Hart,et al.  Contrasting effects of interferon-gamma and interleukin-4 on the interleukin-6 activity of stimulated human monocytes. , 1990, Immunology.

[17]  J. Malter,et al.  Identification of an AUUUA-specific messenger RNA binding protein. , 1989, Science.

[18]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[19]  J. Larrick,et al.  Regulation of macrophage tumor necrosis factor production by prostaglandin E2. , 1986, Biochemical and biophysical research communications.

[20]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1976 .

[21]  Y. Sugimoto,et al.  Prostanoid receptors and their biological actions. , 1993, Progress in lipid research.

[22]  N. Vermeulen,et al.  Comprehensive medicinal chemistry , 1991 .

[23]  P. Hart,et al.  Control by IFN-gamma and PGE2 of TNF alpha and IL-1 production by human monocytes. , 1989, Immunology.